Stimulant use disorder diagnosis and opioid agonist treatment dispensation following release from prison: a cohort study
Saved in:
Palis, H., et al., Stimulant use disorder diagnosis and opioid agonist treatment dispensation following release from prison: a cohort study. Substance Abuse Treatment, Prevention and Policy, vol. 17:77, 2022, 1-11 p.
Ref.
582792
Location:
SIIS R.1834 / SIIS Archivo (R.1834)
Palabras clave:
Exclusión social, Prisión, Ex reclusos, Drogodependencias, Estimulantes, Drogas de síntesis, Diagnóstico dual, Enfermedades mentales, Tratamiento, Opiáceos, Reducción de daños, Sobredosis, Acceso, Estudio comparativo, Canadá
Exclusión social, Prisión, Ex reclusos, Drogodependencias, Estimulantes, Drogas de síntesis, Diagnóstico dual, Enfermedades mentales, Tratamiento, Opiáceos, Reducción de daños, Sobredosis, Acceso, Estudio comparativo, Canadá
Similar Items: Stimulant use disorder diagnosis and opioid agonist treatment dispensation following release from prison: a cohort study
- Impact of opioid substitution therapy for Scotland's prisoners on drug-related deaths soon after prisoner release
- FATAL DRUG OVERDOSE AFTER LIBERATION FROM PRISON: A RETROSPECTIVE STUDY OF FEMALE EX-PRISIONERS FROM STRATHCLYDE REGION (SCOTLAND)
- Effectiveness of pharmacotherapies in increasing treatment retention and reducing opioid overdose death in individuals recently released from prison: a systematic review
- “Expected to happen”: perspectives on post-release overdose from recently incarcerated people with opioid use disorder
- Randomized controlled pilot trial of naloxone-on-release to prevent post-prison opioid overdose deaths
- High risk of overdose death following release from prison: variations in mortality during a 15-year observation period